Published in EMBO J on June 03, 2002
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev (2003) 2.90
Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21
Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu Rev Microbiol (2003) 2.07
Role of survivin and its splice variants in tumorigenesis. Br J Cancer (2005) 1.66
Survivin study: an update of "what is the next wave"? J Cell Physiol (2006) 1.63
Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res (2007) 1.47
A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. EMBO J (2005) 1.45
Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients. J Transl Med (2013) 1.40
Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog (2006) 1.34
The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol (2005) 1.34
Conservation of a triple-helix-forming RNA stability element in noncoding and genomic RNAs of diverse viruses. Cell Rep (2012) 1.34
RNAs in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol (2005) 1.24
A viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression. PLoS Pathog (2011) 1.17
Intracellular localization map of human herpesvirus 8 proteins. J Virol (2007) 1.16
KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog (2012) 1.14
Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation. Mol Cell Biol (2004) 1.10
Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res (2010) 1.09
The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. J Virol (2008) 1.06
Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression. J Biol Chem (2010) 1.06
Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J Virol (2008) 1.02
The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling. Apoptosis (2004) 1.01
Kaposi's sarcoma-associated herpesvirus K7 modulates Rubicon-mediated inhibition of autophagosome maturation. J Virol (2013) 0.99
Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components. J Virol (2007) 0.97
Multicentric Castleman disease: Where are we now? Semin Diagn Pathol (2016) 0.94
Expression level of wild-type survivin in gastric cancer is an independent predictor of survival. World J Gastroenterol (2004) 0.94
Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J Virol (2012) 0.93
A comparative analysis of mitochondrial ORFans: new clues on their origin and role in species with doubly uniparental inheritance of mitochondria. Genome Biol Evol (2013) 0.91
Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity. PLoS Pathog (2008) 0.90
Activation of human herpesvirus replication by apoptosis. J Virol (2013) 0.90
KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development. Infect Agent Cancer (2007) 0.89
Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev (2015) 0.89
Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death. Br J Cancer (2007) 0.87
A lytic viral long noncoding RNA modulates the function of a latent protein. J Virol (2013) 0.87
Next-generation sequence analysis of the genome of RFHVMn, the macaque homolog of Kaposi's sarcoma (KS)-associated herpesvirus, from a KS-like tumor of a pig-tailed macaque. J Virol (2013) 0.87
Molecular biology of KSHV lytic reactivation. Viruses (2015) 0.86
Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry. PLoS Pathog (2012) 0.86
Noncoding RNPs of viral origin. Cold Spring Harb Perspect Biol (2011) 0.86
Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells. Invest New Drugs (2013) 0.85
Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication. Recent Results Cancer Res (2014) 0.84
Apoptosis-induced activation of HIV-1 in latently infected cell lines. Retrovirology (2015) 0.83
Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI. Clin Vaccine Immunol (2007) 0.82
Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer. Cancer Res (2012) 0.82
Novel functions of viral anti-apoptotic factors. Nat Rev Microbiol (2014) 0.81
Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi's Sarcoma and Other AIDS-related Malignancies. Curr Infect Dis Rep (2003) 0.81
Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses. J Immunol Res (2015) 0.81
Viral product trafficking to mitochondria, mechanisms and roles in pathogenesis. Infect Disord Drug Targets (2012) 0.79
Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation. Transl Biomed (2010) 0.79
Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses. Curr Opin Virol (2013) 0.79
Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells. Cancer Sci (2017) 0.75
VDAC3 As a Potential Marker of Mitochondrial Status Is Involved in Cancer and Pathology. Front Oncol (2016) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
Improved sensitivity of profile searches through the use of sequence weights and gap excision. Comput Appl Biosci (1994) 31.96
Mitochondria and apoptosis. Science (1998) 23.41
Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res (2001) 22.33
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res (1995) 21.22
Caspases: enemies within. Science (1998) 19.45
The biochemistry of apoptosis. Nature (2000) 18.91
Death receptors: signaling and modulation. Science (1998) 16.95
The Bcl-2 protein family: arbiters of cell survival. Science (1998) 16.08
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med (1997) 12.65
IAP family proteins--suppressors of apoptosis. Genes Dev (1999) 9.96
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science (1997) 9.73
Inhibition of death receptor signals by cellular FLIP. Nature (1997) 9.58
Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol (1997) 9.18
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (2000) 8.74
Intracellular functions of N-linked glycans. Science (2001) 8.39
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
X-linked IAP is a direct inhibitor of cell-death proteases. Nature (1997) 8.26
Protein function in the post-genomic era. Nature (2000) 7.00
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med (1995) 6.71
BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature (1994) 6.69
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
BCL-2 family: regulators of cell death. Annu Rev Immunol (1998) 6.41
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell (1995) 5.97
Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol (2001) 5.81
Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J (1998) 5.78
IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res (1998) 5.41
Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol (1999) 5.36
A matter of life and cell death. Science (1998) 5.33
IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J (1998) 5.28
Primary structure of the herpesvirus saimiri genome. J Virol (1992) 5.26
Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J (1998) 5.05
p53: death star. Cell (2000) 4.77
The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J (1997) 4.66
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52
CD8+ T cell effector mechanisms in resistance to infection. Annu Rev Immunol (2000) 4.22
Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol (1999) 4.20
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci U S A (1997) 4.07
The preprotein translocase of the mitochondrial inner membrane: function and evolution. J Mol Biol (1999) 3.57
Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol (1998) 3.54
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry (2001) 3.05
Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol (2001) 2.87
Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol (2000) 2.85
p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol (1997) 2.84
Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A (1996) 2.76
Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature (1998) 2.76
Inhibition of fas death signals by FLIPs. Curr Opin Immunol (1998) 2.67
Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol (1998) 2.64
De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J Virol (2002) 2.55
An exegesis of IAPs: salvation and surprises from BIR motifs. Trends Cell Biol (1999) 2.33
A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res (2000) 2.32
Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). J Virol (2001) 2.31
Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem (1998) 2.27
Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem (1998) 2.25
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res (1999) 2.21
Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology (2000) 2.15
The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol (2000) 2.15
Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A (1998) 2.04
Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun (1999) 1.93
Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol (2000) 1.93
The fight of viruses against apoptosis. Curr Opin Genet Dev (1998) 1.88
Viruses and apoptosis. J Gen Virol (1998) 1.80
Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol (2001) 1.78
Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol Cell (2000) 1.77
Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nat Struct Biol (1999) 1.73
Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol Cell (2000) 1.70
Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.65
K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol (2002) 1.65
Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol (1996) 1.64
Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.64
Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell (2000) 1.62
New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level. EMBO J (2001) 1.52
ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein. Mol Cell Biol (1997) 1.49
LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death. Proc Natl Acad Sci U S A (1999) 1.47
Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer (2002) 1.45
Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol (1999) 1.43
From genome to function. Science (2001) 1.43
Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol Cell Biol (2000) 1.39
BAR: An apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci U S A (2000) 1.38
A plant manganese superoxide dismutase is efficiently imported and correctly processed by yeast mitochondria. Proc Natl Acad Sci U S A (1989) 1.29
Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proc Natl Acad Sci U S A (1999) 1.27
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol (2001) 1.27
Boo, a novel negative regulator of cell death, interacts with Apaf-1. EMBO J (1999) 1.23
In vivo localisation and stability of human Mcl-1 using green fluorescent protein (GFP) fusion proteins. FEBS Lett (2000) 1.21
Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus. AIDS (1998) 1.17
Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature (1997) 1.14
The descent of human herpesvirus 8. Semin Cancer Biol (1999) 1.11
A mutational analysis of the baculovirus inhibitor of apoptosis Op-IAP. J Biol Chem (1998) 1.08
Human herpesvirus 8--the first human Rhadinovirus. J Natl Cancer Inst Monogr (1998) 1.05
A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J Biol Chem (2000) 1.05
Origin of eukaryotic programmed cell death: a consequence of aerobic metabolism? Bioessays (1997) 1.04
Identification of the functional regions required for hepatitis D virus replication and transcription by linker-scanning mutagenesis of viral genome. Virology (1997) 1.02
A novel isoform of the mitochondrial outer membrane protein VDAC3 via alternative splicing of a 3-base exon. Functional characteristics and subcellular localization. J Biol Chem (1998) 0.95
Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma. J Invest Dermatol (1999) 0.95
Bcl-xL does not inhibit the function of Apaf-1. Cell Death Differ (2000) 0.94
Failure of Bcl-2 family members to interact with Apaf-1 in normal and apoptotic cells. Cell Death Differ (2000) 0.87
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol (2013) 7.97
Loss of sex discrimination and male-male aggression in mice deficient for TRP2. Science (2002) 4.32
Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer (2010) 3.55
Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet (2004) 3.38
Single-cell transcriptional analysis of neuronal progenitors. Neuron (2003) 3.38
Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci U S A (2007) 2.34
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial. Lancet Oncol (2012) 2.33
Neural crest origins of the neck and shoulder. Nature (2005) 2.31
miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol (2010) 2.29
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood (2002) 2.26
Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin Cancer Res (2011) 2.06
KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci (2003) 2.04
Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci U S A (2003) 1.84
A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70
Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study. PLoS One (2008) 1.70
K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol (2002) 1.65
Small-molecule mimics of an alpha-helix for efficient transport of proteins into cells. Nat Methods (2007) 1.61
Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood (2004) 1.58
A molecular map of mesenchymal tumors. Genome Biol (2005) 1.52
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood (2008) 1.52
The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta (2002) 1.52
KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev (2010) 1.48
Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. Mol Cell (2008) 1.46
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. Cell Host Microbe (2008) 1.35
Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS (2004) 1.34
The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Int J Cancer (2003) 1.34
Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. Hum Mol Genet (2009) 1.33
Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res (2007) 1.33
Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. EMBO J (2005) 1.29
The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood (2012) 1.25
Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda. Int J Cancer (2003) 1.24
LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proc Natl Acad Sci U S A (2004) 1.20
Viral coinfections among African children infected with human immunodeficiency virus type 1. Clin Infect Dis (2003) 1.18
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. Am J Hum Genet (2010) 1.13
Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood (2006) 1.12
KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition. Cell Host Microbe (2011) 1.11
The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. J Virol (2008) 1.06
Neuropilin-2 mediates axonal fasciculation, zonal segregation, but not axonal convergence, of primary accessory olfactory neurons. Neuron (2002) 1.06
Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol (2002) 1.05
Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val654Ala. Mol Cancer Ther (2005) 1.04
LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing. Proc Natl Acad Sci U S A (2010) 1.03
KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PLoS Pathog (2009) 1.02
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat Cell Biol (2012) 0.99
SMG-1 and mTORC1 act antagonistically to regulate response to injury and growth in planarians. PLoS Genet (2012) 0.95
Cancer epigenome. Adv Genet (2010) 0.95
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. Mol Cancer Ther (2009) 0.95
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood (2005) 0.94
Functional expression of secreted proteins from a bicistronic retroviral cassette based on foot-and-mouth disease virus 2A can be position dependent. Hum Gene Ther (2010) 0.93
Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation. Skeletal Radiol (2006) 0.92
Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation. Stem Cells (2013) 0.91
Nodal cis-regulatory elements reveal epiblast and primitive endoderm heterogeneity in the peri-implantation mouse embryo. Dev Biol (2010) 0.90
Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes. J Virol (2003) 0.90
Human feeder cell line for derivation and culture of hESc/hiPSc. Stem Cell Res (2011) 0.89
A comparative study of S/MAR prediction tools. BMC Bioinformatics (2007) 0.88
Lentiviral manipulation of gene expression in human adult and embryonic stem cells. Tissue Eng (2006) 0.87
Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming. Trends Cell Biol (2013) 0.86
Kaposi virus scores cancer coup. Nat Med (2003) 0.86
The hypoxic tumor microenvironment: driving the tumorigenesis of non-small-cell lung cancer. Future Oncol (2014) 0.85
The role of hypoxia in stem cell potency and differentiation. Regen Med (2013) 0.85
Integrated virus-host methylome analysis in head and neck squamous cell carcinoma. Epigenetics (2013) 0.84
The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens. PLoS One (2009) 0.84
Distinct cellular origins of primary effusion lymphoma with and without EBV infection. Leuk Res (2004) 0.84
Extracting fluorescent reporter time courses of cell lineages from high-throughput microscopy at low temporal resolution. PLoS One (2011) 0.84
Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival. Mol Cancer (2014) 0.84
An alignment-free model for comparison of regulatory sequences. Bioinformatics (2010) 0.83
Novel cis-regulatory modules control expression of the Hairy and Enhancer of Split-1 (HES1) transcription factor in myoblasts. J Biol Chem (2011) 0.82
Kaposi sarcoma as a model of oncogenesis and cancer treatment. Expert Rev Anticancer Ther (2007) 0.81
In vitro transformation of mesenchymal stem cells induces gradual genomic hypomethylation. Carcinogenesis (2010) 0.81
Exploring the interaction between siRNA and the SMoC biomolecule transporters: implications for small molecule-mediated delivery of siRNA. Chem Biol Drug Des (2011) 0.80
Focal adhesion kinase is required for KSHV vGPCR signaling. Mol Carcinog (2011) 0.78
A hierarchical model of transcriptional dynamics allows robust estimation of transcription rates in populations of single cells with variable gene copy number. Bioinformatics (2013) 0.78
Redefining KSHV latency. Cell Host Microbe (2013) 0.78
Adrenomedullin haploinsufficiency predisposes to secondary lymphedema. J Invest Dermatol (2013) 0.78
SUMOylation is required for optimal TRAF3 signaling capacity. PLoS One (2013) 0.77
Differential subcellular localisation of the tumour suppressor protein LIMD1 in breast cancer correlates with patient survival. Int J Cancer (2008) 0.77
PU.1 is a major transcriptional activator of the tumour suppressor gene LIMD1. FEBS Lett (2011) 0.77
Linking Kaposi virus to cancer-associated cytokines. Trends Mol Med (2005) 0.77
Targeting EGFR in head and neck cancer: a decade of progress. Nat Clin Pract Oncol (2009) 0.76
Regulators of the hypoxic response: a growing family. Future Oncol (2012) 0.76
Developmental biology: Teeth in double trouble. Nature (2008) 0.75
MicroRNA-mediated gene silencing: are we close to a unifying model? Biomol Concepts (2012) 0.75
RNA interference: a potential tool against Kaposi's sarcoma-associated herpesvirus. Curr Opin Infect Dis (2003) 0.75
Increasing feasibility of optimal gene network estimation. Genome Inform (2004) 0.75
Reduced expression of LIMD1 in ulcerative oral epithelium associated with tobacco and areca nut. Asian Pac J Cancer Prev (2012) 0.75